Aldeyra Therapeutics, Inc.
ALDX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$56 | -$38 | -$62 | -$58 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $8 | $6 | $8 | $7 |
| Change in WC | $6 | $1 | -$3 | $7 |
| Other Non-Cash | -$1 | $0 | $0 | $0 |
| Operating Cash Flow | -$43 | -$30 | -$57 | -$43 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$97 | $0 | -$93 | $0 |
| Inv. Sales/Matur. | $52 | $30 | $63 | $0 |
| Other Inv. Act. | $0 | $0 | -$0 | $0 |
| Investing Cash Flow | -$45 | $30 | -$30 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | -$1 | $0 | $0 |
| Stock Issued | $0 | $0 | $1 | $190 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$1 | $0 | $5 |
| Financing Cash Flow | -$0 | -$1 | $1 | $194 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$88 | -$2 | -$85 | $152 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $143 | $144 | $230 | $78 |
| End Cash | $55 | $143 | $144 | $230 |
| Free Cash Flow | -$43 | -$30 | -$57 | -$43 |